Optimal bandaging of smallpox vaccination sites to decrease the potential for secondary vaccinia transmission without impairing lesion healing

Infection Control and Hospital Epidemiology

Volumn 27, Issue 11, 2006, Pages 1184-1192

  Talbot, Thomas R ^a,c   Peters, Jody ^a   Yan, Lihan ^b   Wright, Peter F ^a   Edwards, Kathryn M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMMES CORPORATION   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; PREDNISONE; SMALLPOX VACCINE;

ADULT; ARTICLE; BANDAGING TECHNIQUE; CHEST TIGHTNESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPNEA; ERYTHEMA MULTIFORME; FACIAL NERVE PARALYSIS; FOAM DRESSING; GAUZE DRESSING; HUMAN; INFECTION CONTROL; INJECTION SITE; INTERMETHOD COMPARISON; IRIDOCYCLITIS; OPEN STUDY; PAPULAR RASH; PERICARDITIS; PUSTULE; RANDOMIZED CONTROLLED TRIAL; RASH; SKIN INDURATION; SKIN IRRITATION; SMALLPOX; THORAX PAIN; VACCINATION; VIRUS CULTURE; VIRUS TRANSMISSION; WOUND HEALING;

ADULT; BANDAGES; HUMANS; MIDDLE AGED; OCCLUSIVE DRESSINGS; SMALLPOX; SMALLPOX VACCINE; TIME FACTORS; TREATMENT OUTCOME; VACCINATION; VACCINIA; VACCINIA VIRUS; WOUND HEALING;

EID: 33751338809     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/508827     Document Type: Article

References (14)

1. Wharton M, Strikas RA, Harpaz R, et al. Recommendations for using smallpox vaccine in a pre-event vaccination program: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 2003; 52:1-16.
2. Sepkowitz KA. How contagious is vaccinia? N Engl J Med 2003; 348:439-446.
3. Centers for Disease Control and Prevention. Smallpox vaccine: vaccination site care and precautions for recipients. Available at http://www .bt.cdc.gov/agent/smallpox/vacanation/vaccination-program-qa.aspitype = cat&cat = Smallpox+Vaccine&subCat1 = Vaccination+Site+Care+and +Precautions+for+Recipients. Accessed November 17, 2005.
4. Talbot TR, Ziel E, Doersam JK, LaFleur B, Tollefson S, Edwards KM. Risk of vaccinia transfer to the hands of vaccinated persons after smallpox immunization. Clin Infect Dis 2004; 38:536-541.
5. Lane JM, Fulginiti VA. Transmission of vaccinia virus and rationale for measures for prevention. Clin Infect Dis 2003; 37:281-284.
6. Cono J, Casey CG, Bell DM. Smallpox vaccination and adverse reactions: guidance for clinicians. MMWR Recomm Rep 2003; 52:1-28.
7. Waibel KH, Ager EP, Topolski RL, Walsh DS. Randomized trial comparing vaccinia on the external surfaces of 3 conventional bandages applied to smallpox vaccination sites in primary vaccinees. Clin Infect Dis 2004; 39:1004-1007.
8. Talbot TR, Stapleton JT, Brady RC, et al. Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial. JAMA 2004; 292:1205-1212.
9. National Cholesterol Education Program. Risk assessment tool for estimating your 10-year risk of having a heart attack. Available at http://hin.nhlbi.nih.gov/atpiii/calculator.asp?usertype = pub. Accessed July 5, 2004.
10. Henderson DA, Inglesby TV, Bartlett JG, et al; Working Group on Civilian Biodefense. Smallpox as a biological weapon: medical and public health management. JAMA 1999; 281:2127-2137.
11. Graham BS, Belshe RB, Clements ML, et al. Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial: The AIDS Vaccine Clinical Trials Network. J Infect Dis 1992; 166:244-252.
12. Hepburn MJ, Dooley DP, Murray CK, et al. Frequency of vaccinia virus isolation on semipermeable versus nonocclusive dressings covering smallpox vaccination sites in hospital personnel. Am J Infect Control 2004; 32:126-130.
13. Cooney EL, Collier AC, Greenberg PD, et al. Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet 1991; 337:567-572.
14. Regules JA, Dooley DP, Hepburn MJ, et al. The effect of semipermeable dressings on smallpox vaccine site evolution. Am J Infect Control 2004; 32:333-336.